# Estrella Immunopharma Inc. (ESLA)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Price:** $1.06 (-7.83%)

> Estrella Immunopharma Inc. is a biotechnology company dedicated to the research and development of innovative therapies. Primarily focusing on creating advanced treatment options for cancer and other serious diseases, the company harnesses cutting-edge technologies to address unmet medical needs. Estrella Immunopharma operates within the highly impactful biopharmaceutical sector, where its contributions can have significant implications for healthcare treatments globally. With a commitment to scientific excellence, the company engages in the discovery of novel drug candidates, advancing them through rigorous clinical trials. Estrella Immunopharma is pivotal in translating scientific innovations into viable medical solutions, contributing to the growing field of personalized medicine. Its role in the market is significant, given the increasing demand for targeted therapies and advancements in medical technology. As a part of the pharmaceutical industry, it not only influences healthcare advancements but also impacts clinical practices, offering potential pathways to improve patient outcomes through novel and effective treatment modalities.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/ESLA)